Magnobovatol inhibits smooth muscle cell migration by suppressing PDGF-Rβ phosphorylation and inhibiting matrix metalloproteinase-2 expression

Kang,Hyreen; Ahn,Dong  Hyeon; Pak,Jhang  Ho; Seo,Kyeong‑Hwa; Baek,Nam-In; Jang,Sung-Wuk

doi:10.3892/ijmm.2016.2548

Magnobovatol inhibits smooth muscle cell migration by suppressing PDGF-Rβ phosphorylation and inhibiting matrix metalloproteinase-2 expression

Authors:
- Hyreen Kang
- Dong Hyeon Ahn
- Jhang Ho Pak
- Kyeong‑Hwa Seo
- Nam-In Baek
- Sung-Wuk Jang
View Affiliations

Affiliations: Department of Biomedical Sciences, University of Ulsan College of Medicine, Seoul 138-736, Rebublic of Korea, Department of Medicine, University of Ulsan College of Medicine, Seoul 138-736, Rebublic of Korea, Asan Institute for Life Sciences, University of Ulsan College of Medicine, Asan Medical Center, Seoul 138-736, Rebublic of Korea, Department of Oriental Medicine Biotechnology, Kyung Hee University, Yongin, Gyeonggi 446-701, Rebublic of Korea
Published online on: April 4, 2016 https://doi.org/10.3892/ijmm.2016.2548
Pages: 1239-1246
Copyright: © Kang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The migration of vascular smooth muscle cells (VSMCs) may play a crucial role in the pathogenesis of vascular diseases, such as atherosclerosis and post-angioplasty restenosis. Platelet-derived growth factor (PDGF)-BB is a potent mitogen for VSMCs and plays an important role in the intimal accumulation of VSMCs. Magnobovatol, a new neolignan from the fruits of Magnolia obovata, has been shown to have anticancer properties. However, the effects of magnobovatol on VSMCs are unknown. In the present study, we examined the effects of magnobovatol on the PDGF‑BB‑induced migration of mouse and human VSMCs, as well as the underlying mechanisms. Magnobovatol significantly inhibited the PDGF‑BB-induced migration of mouse and human VSMCs without inducing cell death (as shown by MTT assay and wound healing assay). Additionally, we demonstrated that magnobovatol significantly blocked the PDGF‑BB-induced phosphorylation of the PDGF receptor (PDGF-R), Akt and extracellular signal‑regulated kinase (ERK)1/2 by inhibiting the activation of the PDGF‑BB signaling pathway. Moreover, in both mouse and human VSMCs, magnobovatol inhibited PDGF-induced matrix metalloproteinase (MMP)-2 expression at the mRNA and protein level, as well as the proteolytic activity of MMP-2 (as shown by western blot analysis, RT-PCR, gelatin zymography and ELISA). In addition, the sprout outgrowth formation of aortic rings induced by PDGF‑BB was inhibited by magnobovatol (as shown by aortic ring assay). Taken together, our findings indicate that magnobovatol inhibits VSMC migration by decreasing MMP-2 expression through PDGF-R and the ERK1/2 and Akt pathways. Our data may improve the understanding of the anti-atherogenic effects of magnobovatol in VSMCs.

View Figures

View References

1	Cidad P, Miguel-Velado E, Ruiz-McDavitt C, Alonso E, Jiménez-Pérez L, Asuaje A, Carmona Y, García-Arribas D, López J, Marroquín Y, et al: Kv1.3 channels modulate human vascular smooth muscle cells proliferation independently of mTOR signaling pathway. Pflugers Arch. 467:1711–1722. 2015. View Article : Google Scholar
2	Owens GK, Kumar MS and Wamhoff BR: Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 84:767–801. 2004. View Article : Google Scholar : PubMed/NCBI
3	Newby AC and Zaltsman AB: Molecular mechanisms in intimal hyperplasia. J Pathol. 190:300–309. 2000. View Article : Google Scholar : PubMed/NCBI
4	Hua Y, Dolence J, Ramanan S, Ren J and Nair S: Bisdemethoxy-curcumin inhibits PDGF-induced vascular smooth muscle cell motility and proliferation. Mol Nutr Food Res. 57:1611–1618. 2013. View Article : Google Scholar : PubMed/NCBI
5	Rudijanto A: The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis. Acta Med Indones. 39:86–93. 2007.PubMed/NCBI
6	Heldin CH, Eriksson U and Ostman A: New members of the platelet-derived growth factor family of mitogens. Arch Biochem Biophys. 398:284–290. 2002. View Article : Google Scholar : PubMed/NCBI
7	Fredriksson L, Li H and Eriksson U: The PDGF family: four gene products form five dimeric isoforms. Cytokine Growth Factor Rev. 15:197–204. 2004. View Article : Google Scholar : PubMed/NCBI
8	Heldin CH and Westermark B: Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev. 79:1283–1316. 1999.PubMed/NCBI
9	Millette E, Rauch BH, Kenagy RD, Daum G and Clowes AW: Platelet-derived growth factor-BB transactivates the fibroblast growth factor receptor to induce proliferation in human smooth muscle cells. Trends Cardiovasc Med. 16:25–28. 2006. View Article : Google Scholar : PubMed/NCBI
10	Muto A, Fitzgerald TN, Pimiento JM, Maloney SP, Teso D, Paszkowiak JJ, Westvik TS, Kudo FA, Nishibe T and Dardik A: Smooth muscle cell signal transduction: implications of vascular biology for vascular surgeons. J Vasc Surg. (Suppl A): A15–A24. 2007. View Article : Google Scholar : PubMed/NCBI
11	Seo J, Lee HS, Ryoo S, Seo JH, Min BS and Lee JH: Tangeretin, a citrus flavonoid, inhibits PGDF-BB-induced proliferation and migration of aortic smooth muscle cells by blocking AKT activation. Eur J Pharmacol. 673:56–64. 2011. View Article : Google Scholar : PubMed/NCBI
12	Zhan Y, Kim S, Izumi Y, Izumiya Y, Nakao T, Miyazaki H and Iwao H: Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression. Arterioscler Thromb Vasc Biol. 23:795–801. 2003. View Article : Google Scholar : PubMed/NCBI
13	Raines EW: PDGF and cardiovascular disease. Cytokine Growth Factor Rev. 15:237–254. 2004. View Article : Google Scholar : PubMed/NCBI
14	Ho JW and Jie M: Pharmacological activity of cardiovascular agents from herbal medicine. Cardiovasc Hematol Agents Med Chem. 5:273–277. 2007. View Article : Google Scholar : PubMed/NCBI
15	Amblard F, Govindarajan B, Lefkove B, Rapp KL, Detorio M, Arbiser JL and Schinazi RF: Synthesis, cytotoxicity, and antiviral activities of new neolignans related to honokiol and magnolol. Bioorg Med Chem Lett. 17:4428–4431. 2007. View Article : Google Scholar : PubMed/NCBI
16	Seo KH, Lee DY, Lee DS, Park JH, Jeong RH, Jung YJ, Shrestha S, Chung IS, Kim GS, Kim YC and Baek NI: Neolignans from the fruits of Magnolia obovata and their inhibition effect on NO production in LPS-induced RAW 264.7 cells. Planta Med. 79:1335–1340. 2013. View Article : Google Scholar : PubMed/NCBI
17	Pyo MK, Yun-Choi HS and Hong YJ: Antiplatelet activities of aporphine alkaloids isolated from leaves of Magnolia obovata. Planta Med. 69:267–269. 2003. View Article : Google Scholar : PubMed/NCBI
18	Pyo MK, Lee Y and Yun-Choi HS: Anti-platelet effect of the constituents isolated from the barks and fruits of Magnolia obovata. Arch Pharm Res. 25:325–328. 2002. View Article : Google Scholar : PubMed/NCBI
19	Youn U, Chen QC, Lee IS, Kim H, Yoo JK, Lee J, Na M, Min BS and Bae K: Two new lignans from the stem bark of Magnolia obovata and their cytotoxic activity. Chem Pharm Bull (Tokyo). 56:115–117. 2008. View Article : Google Scholar
20	Seo KH, Lee DY, Jeong RH, Yoo KH, Chung IS, Kim GS, Seo WD, Kang HC, Ahn EM and Baek NI: Cytotoxicity of Neolignans from Magnolia obovata Fruits. J Appl Biol Chem. 56:179–181. 2013. View Article : Google Scholar
21	Newby AC: Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates. Cardiovasc Res. 69:614–624. 2006. View Article : Google Scholar
22	Johnson C and Galis ZS: Matrix metalloproteinase-2 and -9 differentially regulate smooth muscle cell migration and cell-mediated collagen organization. Arterioscler Thromb Vasc Biol. 24:54–60. 2004. View Article : Google Scholar
23	Risinger GM Jr, Updike DL, Bullen EC, Tomasek JJ and Howard EW: TGF-beta suppresses the upregulation of MMP-2 by vascular smooth muscle cells in response to PDGF-BB. Am J Physiol Cell Physiol. 298:C191–C201. 2010. View Article : Google Scholar
24	Bornfeldt KE, Raines EW, Nakano T, Graves LM, Krebs EG and Ross R: Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. J Clin Invest. 93:1266–1274. 1994. View Article : Google Scholar : PubMed/NCBI
25	Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:801–809. 1993. View Article : Google Scholar : PubMed/NCBI
26	Ferns GA, Raines EW, Sprugel KH, Motani AS, Reidy MA and Ross R: Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science. 253:1129–1132. 1991. View Article : Google Scholar : PubMed/NCBI
27	Sirois MG, Simons M and Edelman ER: Antisense oligonucleotide inhibition of PDGFR-beta receptor subunit expression directs suppression of intimal thickening. Circulation. 95:669–676. 1997. View Article : Google Scholar : PubMed/NCBI
28	Risinger GM Jr, Hunt TS, Updike DL, Bullen EC and Howard EW: Matrix metalloproteinase-2 expression by vascular smooth muscle cells is mediated by both stimulatory and inhibitory signals in response to growth factors. J Biol Chem. 281:25915–25925. 2006. View Article : Google Scholar : PubMed/NCBI
29	Beaudeux JL, Giral P, Bruckert E, Foglietti MJ and Chapman MJ: Matrix metalloproteinases and atherosclerosis. Therapeutic aspects. Ann Biol Clin (Paris). 61:147–158. 2003.In French.
30	Kuzuya M and Iguchi A: Role of matrix metalloproteinases in vascular remodeling. J Atheroscler Thromb. 10:275–282. 2003. View Article : Google Scholar